|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 新一代渴望导管: 在肺的栓塞的处理的可行性显示文摘 AIM: To report our preliminary experience with a new generation aspiration catheter in the treatment of symptomatic pulmonary embolism(PE). METHODS: A retrospective database search for pulmonary artery embolectomy since introduction of the Pronto.035' and XL extraction catheter(Vascular Solutions, Minneapolis, MN) at our institution in 10/2009 was performed. Ten consecutive patients were identified in which the Pronto.035' or XL catheter was used between 01/2010 and 03/2013. All patients were referred for catheter based embolectomy due to contraindications to systemic lysis, or for being in such a critical clinical condition that immediate percutaneous treatment deemed warranted. The computed tomography(CT) right to left heart ratio as predictor for the severity of the PE was retrospectively evaluated on standard axial views. The difference between pre- and post-procedure pulmonary pressure measures was taken to assess the procedural effect.RESULTS: Extensive PE was confirmed angiographically in all patients. Measured right- to left ventricle(RV/LV) ratios were elevated beyond one in seven of the eight available CTs. Acute procedural success defined as clinical removal of visible thrombus and improvement in mean pulmonary artery pressure was seen in all recorded patients(n = 8), the mean pulmonary pressures declined from a median(range) of 35.5(19-46) to 23(10-37, P = 0.008) mmHg. Neither death nor other complications occurred intra- or immediately periprocedural, yet short term mortality within 30 d was found in 6 out of 9 patients, one patient was lost in follow up. The cause of death within 30 d in the 6 patients was identified as: Circulatory failure in direct connection with the PE(n = 2), stroke, sepsis, or succumbing to malignancy in a hospice setting(n = 2). CONCLUSION: Success in thrombus removal with improved pulmonary hypertension and systemic hypotension suggests this aspiration technique to be effective. Aspiration catheters should be part of further trials. | Wolf E Heberlein Mollie E Meek Omar Saleh James C Meek Shelly Y Lensing William C Culp | 2013 | World Journal of Radiology2013，5，11： | 2 |
| 2 | Body surface area adapted iopromide 300 mg/ml versus 370 mg/mL contrast medium injection protocol:influence on quantitative and clinical assessment in combined PET/CT 显示文摘 | Verburg FA Apitzsch J Lensing C | 2013 | Eur J Radio12013，82，12： | 1 |
| 3 | Body surface area adapted iopromide 300 mg/mL versus 370 mg/mL contrast medium injection protocol:influence on quantitative And clinical assessment in com- bined PET/CT显示文摘 | Verburg F A Apitzsch J Lensing C | 2013 | Eur J Radiol2013，82，12： | 1 |
| 4 | Effects of music on physiolog-ical and behavioral indices of acute pain and stress in premature in-fants :Clinical trial and literature review 显示文摘 | Tramo MJ Lense M Van Ness C | 2011 | Music and Medicine2011，3，2： | 1 |
| 5 | Ventilation/perfusion scanning and the diagnosis of pulmonary embolism:improvement of observer agreement by the use of a lung segment reference chart显示文摘 | Lensing AWA van Beek E JR Demers C | 1992 | Thromb Haemostas1992，68，4： | 1 |
| 6 | Phase Ⅰ trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points 显示文摘 | BIBLE K C LENSING J L NELSON S A | 2005 | Clin Cancer Res2005，11，16： | 1 |
| 7 | 查看详情显示文摘 | Besson C Huang Z Geletii Y.V Lense S Hardcastle K.1 Musaev D.G Lian T Proust A Hill C.L | | 0，，： | 1 |
| 8 | 查看详情显示文摘 | Zhu G Geletii Y.V Kogerler P Schilder H Song J Lense S Zhao C Hardcastle K.I Musaev D.G Hill C.L | | 0，，： | 1 |
| 9 | Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT 显示文摘 | Verburg FA Apitzsch J Lensing C | 2013 | Eur J Radiol2013，82，12： | 1 |
| 10 | Yttrium Hydrogen trapping to manage hydrogen in hsla steel welds显示文摘 | Lensing C A Park Y D Maroef I S | 2004 | Welding Journal2004，83，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员